The tumor volumes in the mice in the LV-GFP-CDX2 group were significantly smaller compared with those of the control groups (P<0.05) at 15 days post-tumor injection, whereas no difference was identified between the Lv-GFP-NC and PBS groups (P>0.05; Fig. 2B). Here, CDX2 is linked to neoplasm.